| Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory Drugs (NCT00634985) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2002-11-01 |
| A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin (NCT00645034) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2002-11-01 |
| To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients. (NCT00151502) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2002-11-01 |
| A Ten-Week Study Evaluating The Effectiveness And Safety Of Zoloft In Children And Adolescents With A Diagnosis Of PTSD (NCT00150306) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2002-11-01 |
| A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial Hypertension (NCT00644605) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2002-10-01 |
| A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression (NCT00644982) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2002-10-01 |
| A Study Evaluating the Efficacy and Safety of Sildenafil in Patients With Erectile Dysfunction Receiving Hemodialysis (NCT00654017) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2002-10-01 |
| Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (United States) (NCT00620867) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2002-10-01 |
| A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction (NCT00654082) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2002-09-01 |
| Sildenafil For Meniere's Disease (NCT00145483) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2002-06-18 |
| Comparative Atorvastatin Pleiotropic Effects (NCT00163202) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2002-06-01 |
| Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia (NCT00139737) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2002-03-01 |
| Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US (NCT00847483) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2002-01-01 |
| Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients (NCT00159770) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2001-11-01 |
| Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031 (NCT00174447) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2001-10-01 |
| Double Blind Atorvastatin Amlodipine Study (NCT00159718) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2001-07-01 |
| Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina (NCT00143195) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2001-04-01 |
| Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study (NCT01859481) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2000-03-01 |
| Atorvastatin For The Reduction Of Ventricular Arrhythmias (NCT00457340) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2000-02-01 |
| Non-Interventional Study In Patients With Ocular Hypertension And Open Angle Glaucoma Treated With Xalatan And Xalacom (NCT01012245) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2000-01-01 |
| Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan (NCT01989936) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1999-01-01 |
| A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients (NCT00856622) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1997-08-01 |
| A Study of Glaucoma or Ocular Hypertension in Patients Within the United States (NCT00800267) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1997-07-01 |
| Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo (NCT01986270) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1996-12-01 |
| Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study (NCT01986088) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1996-11-01 |
| Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine (NCT01978496) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1996-07-01 |
| A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom (NCT00751049) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1992-12-01 |
| A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia (NCT00751062) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1992-11-01 |
| Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil (NCT01897740) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | |
| Corneal Versus Conjunctival Delivery Using a Delivery Device (NCT00143429) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | |
| Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil (NCT00866983) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | |
| Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study (NCT00878943) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | |
| Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device (NCT00283764) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | |
| An Open Label Access Study For Subjects Who Completed A1481156 (NCT01582438) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | |